((自动化翻译由路透提供,请见免责声明 ))
路透1月8日 - 强生公司(Johnson & Johnson )周三表示,该公司已暂时停止在美国推广其Varipulse心脏设备,理由是该公司正在调查四起中风事件报告,因此必须慎之又慎。
Varipulse是一种脉冲场消融系统,于11月获得美国食品和药物管理局批准,用于治疗一种异常心律状况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.